TxCell - Robust and stable Treg manufacturing
TxCell has disclosed that it has a viable manufacturing route for its novel CAR Treg products. This uses a stable but low-frequency Treg cell type....
96 Views
Humanised CAR Tregs are a key step forward
TxCell has announced it has a promising humanised CAR-Treg product that can be developed to control graft rejection in solid organ transplant. A...
52 Views
Getting production in order
TxCell has agreed an important manufacturing supply contract with Lentigen, a German-US producer of the critical lentivirus reagent essential for...
42 Views
Aiming for first CAR Treg
TxCell’s novel CAR-modified regulatory T-cell (CAR Treg) platform continues to develop well. TxCell has four indications in preclinical development...
66 Views
Exciting CAR opportunities; multiple indications
TxCell’s novel CAR-modified regulatory T-cell (CAR Treg) platform is developing well. CAR Tregs offer a powerful and versatile new approach to...
44 Views
No more insights